HKD 1.64
(1.86%)
Year | Net Income | Net Income Growth |
---|---|---|
2023 | 10.8 Million USD | -58.0% |
2022 | 25.73 Million USD | 39.65% |
2021 | 18.42 Million USD | 7.45% |
2020 | 17.15 Million USD | -6.91% |
2019 | 18.42 Million USD | 63.9% |
2018 | 11.24 Million USD | 10.59% |
2017 | 10.16 Million USD | 52.95% |
2016 | 6.64 Million USD | 0.0% |
Year | Net Income | Net Income Growth |
---|---|---|
2024 Q2 | -117 Thousand USD | 0.0% |
2023 Q4 | 6.21 Million USD | 0.0% |
2023 Q2 | 4.59 Million USD | 0.0% |
2023 FY | 10.8 Million USD | -58.0% |
2022 FY | 25.73 Million USD | 39.65% |
2022 Q2 | 12.94 Million USD | 0.0% |
2022 Q4 | 12.79 Million USD | 0.0% |
2021 Q2 | 8.83 Million USD | 0.0% |
2021 FY | 18.42 Million USD | 7.45% |
2021 Q4 | 9.59 Million USD | 0.0% |
2020 Q4 | 12.75 Million USD | 0.0% |
2020 Q2 | 4.39 Million USD | 0.0% |
2020 FY | 17.15 Million USD | -6.91% |
2019 Q4 | 9.13 Million USD | 0.0% |
2019 FY | 18.42 Million USD | 63.9% |
2019 Q2 | 9.29 Million USD | 0.0% |
2018 Q2 | 2.79 Million USD | 0.0% |
2018 Q4 | 8.45 Million USD | 0.0% |
2018 FY | 11.24 Million USD | 10.59% |
2017 Q1 | 2.54 Million USD | 0.0% |
2017 FY | 10.16 Million USD | 52.95% |
2017 Q4 | 2.81 Million USD | 0.0% |
2017 Q2 | 2.54 Million USD | 0.0% |
2016 Q4 | 2.54 Million USD | 0.0% |
2016 FY | 6.64 Million USD | 0.0% |
2016 Q1 | 1.8 Million USD | 0.0% |
2016 Q2 | 1.8 Million USD | 0.0% |
2015 Q4 | 1.8 Million USD | 0.0% |
Name | Net Income | Net Income Difference |
---|---|---|
Uni-Bio Science Group Limited | 70.87 Million HKD | 84.751% |
CK Life Sciences Int'l., (Holdings) Inc. | 17.25 Million HKD | 37.345% |